Moody’s affirms ‘ Baa2′ bond rating for King’s Daughters’ Health

Moody’s Investors Service affirmed its “Baa2” rating on series 2010 revenue bonds for Madison, Ind.-based King’s Daughters’ Health.

Advertisement

The affirmation is a result of several factors including the hospital’s strong market position, limited competition, healthy financial performance and improving liquidity metrics. Moody’s also acknowledged KDH’s small operating size, heavy debt burden and variable operating performance.

The outlook is stable reflecting Moody’s expectation that operating performance will continue to help liquidity metrics improve to offset the large debt load. 

More articles on healthcare finance:
Lurie Children’s Hospital receives $3.5M from Chicago Cubs first baseman
17 donations, grants to healthcare organizations in August
6 recent hospital, health system outlook and credit rating actions

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.